🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalCanadian GLP-1 coverage — anyone have experience? Page 6

Canadian GLP-1 coverage — anyone have experience?

lisa_labSD Thu, Apr 2, 2026 at 1:16 AM 36 replies 1,378 viewsPage 6 of 8
alex_tucson
Member
567
2,345
May 2024
Tucson, AZ
Apr 9, 2026 at 3:21 PM#26

Following on from Dr.Martinez — and this may be the naive question:

What would you measure differently if you were starting again?

19 17emily_PDX, Dr.SleepRoch, laura_annarbor and 16 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Apr 10, 2026 at 11:38 AM#27
PeptideSynthNJ said:
One practical note: write down what you did and when, before you need it.

I read this differently from PeptideSynthNJ, on substance rather than tone. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

That is the short version; the long version is somebody else's post.

20 18dave_SLC, FDA_TrackerJim, ricardo_MIA and 17 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Apr 11, 2026 at 7:54 AM#28
PeptideSynthNJ said:
One practical note: write down what you did and when, before you need it.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

Correct me if the detail matters more than I have assumed.

21 19Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 18 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Apr 12, 2026 at 4:10 AM#29
PeptideSynthNJ said:
One practical note: write down what you did and when, before you need it.

This is exactly what I could not find anywhere else. I will report back once I have actually tried it.

22 20LondonLisa, mike_nyc, VendorMark and 19 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Apr 13, 2026 at 12:25 AM#30

Reporting back.

Update: approved on the third attempt after a peer-to-peer. Nothing about my case changed; only who was doing the talking.

44 17cory_ATX, lori_vegas, Dr.PulmRoch and 41 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register